Biohaven Ltd.: Canaccord Genuity raises target price to $32 from $21
BHVN•Canaccord Genuity raised its target price for Biohaven Ltd. to $32 from $21.
Related News
Morgan Stanley cuts Bristol-Myers Squibb target price to $40 from $41
BMY•
Société Générale issues EUR 30 million in senior preferred notes
SCGLY•
Japan government reportedly requests US AI firms to expand access to AI models to counter cyberattacks
XLK•
Nasdaq trade halt continues, reason not available at 04:00 am
TJGC•
Caterpillar target price cut to $675 from $915 by Morgan Stanley
CAT•